================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-1004
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 8, 2005
CIPHERGEN BIOSYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 000-31617 33-059-5156
(State or other jurisdiction of [Commission (I.R.S. Employer
incorporation or organization) File Number] Identification Number)
6611 Dumbarton Circle
Fremont, CA 94555
(Address of principal executive offices)
(510) 505-2100
(Registrant's telephone number, including area code)
================================================================================
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 8, 2005, Ciphergen Biosystems, Inc. issued a press release
announcing financial results for its fiscal second quarter ended June 30, 2005.
The press release is attached as Exhibit 99.1 to this Form 8-K.
The information in this Current Report on Form 8-K is being furnished and
shall not be deemed "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS.
EXHIBIT NO. DESCRIPTION
----------- ----------------------------------------------------------------
99.1 Press Release issued by Ciphergen Biosystems, Inc. on
August 8, 2005
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CIPHERGEN BIOSYSTEMS, INC.
(Registrant)
Date: August 9, 2005 By: /S/ WILLIAM E. RICH
-----------------------
William E. Rich
Chief Executive Officer
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
----------- ----------------------------------------------------------------
99.1 Press Release issued by Ciphergen Biosystems, Inc. on
August 8, 2005